美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件: 药品名称=AMIKIN
符合检索条件的记录共8
1 页 当前第 1 页  返回检索页
1药品名称AMIKIN
申请号050495产品号001
活性成分AMIKACIN SULFATE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格EQ 50MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构APOTHECON INC DIV BRISTOL MYERS SQUIBB
2药品名称AMIKIN
申请号050495产品号002
活性成分AMIKACIN SULFATE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格EQ 250MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构APOTHECON INC DIV BRISTOL MYERS SQUIBB
3药品名称AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
申请号050618产品号001
活性成分AMIKACIN SULFATE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格EQ 10MG BASE/ML
治疗等效代码参比药物
批准日期1987/11/30申请机构APOTHECON INC DIV BRISTOL MYERS SQUIBB
4药品名称AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
申请号050618产品号002
活性成分AMIKACIN SULFATE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格EQ 5MG BASE/ML
治疗等效代码参比药物
批准日期1987/11/30申请机构APOTHECON INC DIV BRISTOL MYERS SQUIBB
5药品名称AMIKIN
申请号062311产品号001
活性成分AMIKACIN SULFATE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格EQ 50MG BASE/ML
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构APOTHECON INC DIV BRISTOL MYERS SQUIBB
6药品名称AMIKIN
申请号062311产品号002
活性成分AMIKACIN SULFATE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格EQ 250MG BASE/ML
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构APOTHECON INC DIV BRISTOL MYERS SQUIBB
7药品名称AMIKIN
申请号062562产品号001
活性成分AMIKACIN SULFATE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格EQ 50MG BASE/ML
治疗等效代码参比药物
批准日期1984/09/20申请机构APOTHECON INC DIV BRISTOL MYERS SQUIBB
8药品名称AMIKIN
申请号062562产品号002
活性成分AMIKACIN SULFATE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格EQ 250MG BASE/ML
治疗等效代码参比药物
批准日期1984/09/20申请机构APOTHECON INC DIV BRISTOL MYERS SQUIBB